| Pharmaceutical active ingredients: |
| Cinnarizine |
| Available forms, composition and doses of Cerebolan: |
| N / A |
| Cerebolan medical category: |
| Human:Antivertigo drugsPeripheral vasodilators and cerebral activators |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07CA02 - Cinnarizine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cerazol | Sulfathiazole | Unidentified Pharmaceutical Company |
| Cerazole | Sulfathiazole | Unidentified Pharmaceutical Company |
| Cercine | Diazepam | Unidentified Pharmaceutical Company |
| Cereb | Citicoline | Unidentified Pharmaceutical Company |
| Cerebid | Papaverine | Unidentified Pharmaceutical Company |
| Cerebon | Meclofenoxate | Unidentified Pharmaceutical Company |
| Cerebro | Suloctidil | Unidentified Pharmaceutical Company |
| Cerebro-Nicin | Pentetrazol | Unidentified Pharmaceutical Company |
| Cerebrose | Galactose | Unidentified Pharmaceutical Company |
| Ceregulart | Diazepam | Unidentified Pharmaceutical Company |